Dr. Pashtoon Kasi, MS
Claim this profileUniversity of Iowa/Holden Comprehensive Cancer Center
Expert in Colorectal Cancer
Studies Adenocarcinoma
19 reported clinical trials
48 drugs studied
About Pashtoon Kasi, MS
Education:
- Earned an MD from Aga Khan University (AKU) in Pakistan, 2006.
- Completed an MS at Mayo Graduate School of Graduate Medical Education (MSGME), Mayo Clinic, 2018.
Experience:
- Completed a Fellowship in Oncology and Hematology at Mayo Clinic in 2016.
- Served as Associate and Assistant Professor of Medicine and Oncology at the University of Iowa and Mayo Clinic.
- Currently an oncologist and researcher at Weill Cornell Medicine and NewYork-Presbyterian Hospital, with a focus on gastrointestinal cancers.
- Holds the position of Director for Colorectal Cancer Research and Precision Medicine Director for Liquid Biopsy Research at the Englander Institute of Precision Medicine.
Area of expertise
1Colorectal Cancer
Global LeaderStage IV
Stage III
Stage I
2Adenocarcinoma
Stage IV
HER2 positive
Stage III
Affiliated Hospitals
Clinical Trials Pashtoon Kasi, MS is currently running
Immunotherapy + Chemotherapy
for Rectal Cancer
This trial uses a combination of radiation therapy, medication, and chemotherapy to treat patients with advanced pelvic tumors. The goal is to shrink the tumors, kill cancer cells, and enhance the overall effectiveness of the treatment.
Recruiting1 award Phase 22 criteria
Botensilimab + Chemotherapy
for Pancreatic Cancer
This trial is testing whether adding a new drug, botensilimab, to standard chemotherapy can better treat patients with advanced pancreatic cancer. The study will ensure the new drug is safe and determine the right dose. It will also compare the effectiveness of the new combination treatment to chemotherapy alone.
Recruiting1 award Phase 2
More about Pashtoon Kasi, MS
Clinical Trial Related2 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Pashtoon Kasi, MS has experience with
- Irinotecan
- Oxaliplatin
- Trastuzumab
- Tucatinib
- Ramucirumab
- Paclitaxel
Breakdown of trials Pashtoon Kasi, MS has run
Colorectal Cancer
Adenocarcinoma
Gastroesophageal Junction Adenocarcinoma
Esophageal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Pashtoon Kasi, MS specialize in?
Pashtoon Kasi, MS focuses on Colorectal Cancer and Adenocarcinoma. In particular, much of their work with Colorectal Cancer has involved Stage IV patients, or patients who are Stage III.
Is Pashtoon Kasi, MS currently recruiting for clinical trials?
Yes, Pashtoon Kasi, MS is currently recruiting for 9 clinical trials in Iowa City Iowa. If you're interested in participating, you should apply.
Are there any treatments that Pashtoon Kasi, MS has studied deeply?
Yes, Pashtoon Kasi, MS has studied treatments such as Irinotecan, Oxaliplatin, Trastuzumab.
What is the best way to schedule an appointment with Pashtoon Kasi, MS?
Apply for one of the trials that Pashtoon Kasi, MS is conducting.
What is the office address of Pashtoon Kasi, MS?
The office of Pashtoon Kasi, MS is located at: University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa 52242 United States. This is the address for their practice at the University of Iowa/Holden Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.